Published in J Clin Endocrinol Metab on July 01, 1969
Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J Clin Invest (1970) 2.23
Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J Clin Invest (1970) 1.48
The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest (1976) 1.38
Androgen dynamics in vitro in the normal and hyperplastic human prostate gland. Biochem J (1971) 1.26
Pharmacology of anabolic steroids. Br J Pharmacol (2008) 1.26
Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization. J Clin Invest (1972) 1.08
The source of plasma dihydrotestosterone in man. J Clin Invest (1971) 1.05
The effect of oestrogen on the prostatic metabolism of testosterone in tissue culture. Biochem J (1971) 0.94
Epididymis cholesterol homeostasis and sperm fertilizing ability. Asian J Androl (2010) 0.90
3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism. J Clin Invest (1982) 0.83
Effects of steriod hormones on human fibroblasts in vitro. II. Antagonism by androgens of cortisol-induced inhibition. Ann Rheum Dis (1976) 0.81
Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia. J Clin Invest (1980) 0.81
Solubilization and partial characterization of rat epididymal delta 4-steroid 5 alpha-reductase (cholestenone 5 alpha-reductase). Biochem J (1983) 0.80
The metabolism of testosterone and dihydrotestosterone in an androgen-dependent tumour. A possible correlation between dihydrotestosterone and tumour growth in vivo. Biochem J (1972) 0.76
Testosterone. Can Med Assoc J (1970) 0.75
Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia. Lancet (1971) 7.25
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med (1998) 5.33
Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet (1981) 4.28
Gestational diabetes mellitus--management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust (1998) 4.05
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med (1996) 3.94
Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem (1994) 3.87
The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem (1968) 3.54
Peer review and publication. Presidential address before the 70th annual meeting of the American Society for Clinical Investigation, San Francisco, California, 30 April 1978. J Clin Invest (1978) 3.12
GROWTH OF YOUNG WHEAT PLANTS IN AUTO-IRRIGATED SOILS, AS RELATED TO THE WATER-SUPPLYING POWER OF THE SOIL AND TO THE ADJUSTMENT OF THE AUTO-IRRIGATOR. Plant Physiol (1926) 2.91
Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A (1989) 2.49
Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet (1994) 2.35
Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med (1974) 2.27
Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J Clin Invest (1970) 2.23
Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest (1990) 2.12
The syndromes of androgen resistance. N Engl J Med (1980) 2.05
Opportunities for medical research in the 21st century. JAMA (2001) 2.01
Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Lab Invest (1984) 1.99
The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate. J Biol Chem (1968) 1.98
The pathogenesis of benign prostatic hyperplasia. Am J Med (1980) 1.97
Antinuclear antibodies in patients receiving non-practolol beta-blockers. Br Med J (1978) 1.91
The hormonal control of sexual development. Science (1981) 1.88
Regulation of cholesterol metabolism. I. N Engl J Med (1970) 1.86
Congenital absence of the vagina. The Mayer-Rokitansky-Kuster-Hauser syndrome. Ann Intern Med (1976) 1.81
The conversion of testosterone to 5 alpha-androstan-17 beta-ol-3-one (dihydrotestosterone) by skin slices of man. J Clin Invest (1969) 1.75
Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology (1990) 1.64
Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol Cell Endocrinol (1992) 1.60
Studies on the influence of dietary cholesterol on cholesterol metabolism in the isotopic steady state in man. J Clin Invest (1965) 1.59
Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab (1974) 1.59
Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance. J Clin Invest (1976) 1.55
Bile salt and micellar fat concentration in proximal small bowel contents of ileectomy patients. J Clin Invest (1968) 1.53
The use and misuse of androgens. Metabolism (1980) 1.52
Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control. J Clin Invest (1968) 1.51
Testicular feminization in a cat. J Am Vet Med Assoc (1989) 1.51
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab (1992) 1.51
Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J Clin Invest (1970) 1.48
Familial incomplete male pseudohermaphroditism, type 1. Evidence for androgen resistance and variable clinical manifestations in a family with the Reifenstein syndrome. N Engl J Med (1974) 1.48
Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest (1991) 1.42
Hereditary fructose intolerance in an adult. Aust N Z J Med (1995) 1.40
Genetic and endocrine control of renin activity in the submaxillary gland of the mouse. Biochem Genet (1981) 1.39
The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest (1976) 1.38
Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ (1999) 1.37
THE MEASUREMENT AND INTERPRETATION OF THE WATER-SUPPLYING POWER OF THE SOIL WITH SPECIAL REFERENCE TO LAWN GRASSES AND SOME OTHER PLANTS. Plant Physiol (1927) 1.36
Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest (1992) 1.36
Location on chromosome 1 of Rnr, a gene that regulates renin in the submaxillary gland of the mouse. Proc Natl Acad Sci U S A (1978) 1.35
The pathogenesis of gynecomastia. Adv Intern Med (1980) 1.31
Death and division of lymphocytes. Neglected factors in assessment of P.H.A.-induced transformation. Lancet (1968) 1.30
T and B rosette-forming cells. Eur J Immunol (1971) 1.29
Spontaneous rosettes as a T-lymphocyte marker: a modified method giving consistent results. SRBC rosettes. J Immunol Methods (1974) 1.28
A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf) (1991) 1.26
Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab (1993) 1.22
Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab (1979) 1.22
The measurement of the exchangeable pools of cholesterol in the baboon. J Clin Invest (1970) 1.22
Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest (1999) 1.20
The relationship of antibody-forming cells to rosette-forming cells. Immunology (1971) 1.20
Colposcopy and cervical biopsy of patients with inflammatory cytology. Community Med (1987) 1.19
Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Mol Endocrinol (1990) 1.19
Sexual differentiation. Annu Rev Physiol (1978) 1.18
Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol (1991) 1.18
Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med (1979) 1.17
The quantification of cholesterol excretion and degradation in the isotopic steady state in the rat: the influence of dietary cholesterol. J Lipid Res (1964) 1.17
The identification of Fc and C3 receptors on human neutrophils. J Immunol Methods (1975) 1.16
Diminished 5alpha-reductase activity in extracts of fibroblasts cultured from patients with familial incomplete male pseudohermaphroditism, type 2. J Biol Chem (1975) 1.16
Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. J Clin Invest (1992) 1.15
The intranuclear metabolism of testosterone in the accessory organs of reproduction. Recent Prog Horm Res (1970) 1.14
A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance. J Clin Invest (1990) 1.13
Steroid 5alpha-reductase in cultured human fibroblasts. Biochemical and genetic evidence for two distinct enzyme activities. J Biol Chem (1976) 1.12
Recent studies on the mechanism of action of testosterone. N Engl J Med (1972) 1.12
Androgen resistance caused by mutations in the androgen receptor gene. FASEB J (1991) 1.11
The role of gonadal steroids in sexual differentiation. Recent Prog Horm Res (1981) 1.11
Quantitative deposition of ultrafine stable particles in the human respiratory tract. J Appl Physiol (1985) (1985) 1.11
Dihydrotestosterone formation in cultured human fibroblasts. Comparison of cells from normal subjects and patients with familial incomplete male pseudohermaphroditism, Type 2. J Biol Chem (1975) 1.10
Hemochromatosis in association with hereditary spherocyto- sis. Arch Intern Med (1967) 1.10
Transfer of locally synthesized cholesterol from intestinal wall to intestinal lymph. J Lipid Res (1968) 1.09
Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase. Proc Natl Acad Sci U S A (1991) 1.09
Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization. J Clin Invest (1972) 1.08
WATER-SUPPLYING POWER OF THE SOIL UNDER DIFFERENT SPECIES OF GRASS AND WITH DIFFERENT RATES OF WATER APPLICATION. Plant Physiol (1931) 1.08
The formation of 5alpha-androstane-3alpha, 17beta-diol by dog prostate. Endocrinology (1976) 1.08
Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry (1994) 1.08
Theophylline, beta-agonists, and fatal asthma. Lancet (1981) 1.07
Understanding dynamics of the system using Hilbert phases: an application to study neonatal and fetal brain signals. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.07
Genetic control of renin activity in the submaxillary gland of the mouse. Proc Natl Acad Sci U S A (1977) 1.07
Studies on the mechanism of 3 alpha-androstanediol-induced growth of the dog prostate. Endocrinology (1978) 1.06
Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab (1996) 1.06
Human fetal brain imaging by magnetoencephalography: verification of fetal brain signals by comparison with fetal brain models. Neuroimage (2004) 1.06
Characterization of the cytosol androgen receptor of the human prostate. J Clin Endocrinol Metab (1983) 1.05
Surface immunoglobulins on lymphocytes in chronic lymphocytic leukaemia and lymphosarcoma. Br J Haematol (1973) 1.05
Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity. Clin Exp Immunol (1981) 1.05
Hereditary male pseudohermaphroditism associated with an unstable form of 5 alpha-reductase. J Clin Invest (1978) 1.05
Human T lymphocyte colonies in agar: a comparison with other T cell assays in healthy subjects and cancer patients. Aust J Exp Biol Med Sci (1976) 1.05
Patients' attitudes to the presence of medical students in a genitourinary medicine clinic: a cross sectional survey. Sex Transm Infect (2006) 1.04
Regulation of human hair growth by steroid hormones. I. Testerone metabolism in isolated hairs. J Clin Endocrinol Metab (1974) 1.04
Metabolic characteristics of lymphocyte surface immunoglobulins. Eur J Immunol (1972) 1.04
Studies on the pathogenesis of the incomplete forms of androgen resistance in man. J Clin Endocrinol Metab (1977) 1.04
T-lymphocyte colonies in malignant disease. Lancet (1976) 1.04
Allopurinol in the treatment of uraemic patients with gout. Ann Rheum Dis (1967) 1.04
Antinuclear antibodies and cardiovascular drugs. Drugs (1980) 1.03
Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol Endocrinol (1992) 1.03